Vaporizer Regulations Imposed By FDA Impose Strain On Some Vape Startups

The U.S. Food and Drug Administration (FDA) announced new regulations for the vapor industry late last year and the result, according to one vaporizer manufacturer’s analysis, is that many of the smaller vape companies will suffer from the new obligations imposed upon them by the FDA. These new obligations include the requirement of manufacturers to submit certifications and documentation to the FDA for review.

But on the other hand, while it may have a negative impact on some manufacturers, there are those who believe that such regulations do have their place in the industry. Take Haze Technologies for example, makers of the Haze vaporizers. According to Haze, they believe that the FDA’s new regulations are a necessity, as they wrote on their website that they “believe that the regulations are necessary to ensure good quality vape products are placed on the shelves.”

“Although we believe in business growth and equal opportunity for all manufacturers to take their place in the market, we also believe that the regulations are necessary to ensure good quality vape products are placed on the shelves. This is necessary not only from the public safety perspective but also for the future growth of the industry.”

As of present, the FDA requires vape manufacturers to submit their products for approval before they can be sold within the United States. For consumers, this is a double-edged sword. On one side, the FDA oversight has the potential to help reduce the number of unsafe vaporizers on the market. But on the other side, it also cuts down on the number new vapes hitting the market, or at the least, delays their release.

We can see how this could have a negative impact on smaller companies, especially underfunded startups that are still trying to establish themselves in the industry. For a smaller company, the legal resources and man hours necessary to submit the required documentation and certifications could prove to be a real hassle, whereas larger companies may hardly notice the costs incurred.

What do you think of these new regulations and the FDA’s decision to regulate the industry in general? Share your thoughts in the comments section below.